Resumo

BERNI, Ana C.; WAMBOLDT, Rachel  e  BARANCHUK, Adrián. Arrhythmias in transgender individuals. Arch. Cardiol. Méx. [online]. 2023, vol.93, suppl.3, pp.18-22.  Epub 12-Dez-2023. ISSN 1665-1731.  https://doi.org/10.24875/acm.m23000089.

The need to improve access to health services for the transgender community has become evident, especially concerning cardiovascular risk, which is higher compared to the general population. Surgical procedures and hormone therapies are common in this population to affirm gender identity, but they pose challenges as they are associated with disruptions in lipid metabolism, body fat concentration, and insulin resistance. Additionally, there is an increased risk of adverse cardiovascular events such as venous thromboembolism, stroke, and myocardial infarction. The influence of sex hormones on the electrophysiological properties of the heart has been studied, highlighting gender differences that may predispose the transgender population to cardiac arrhythmias. Exogenous hormone therapy, for both transgender women and men, can affect the QT interval and increase the risk of arrhythmias, including atrial fibrillation. Although the incidence of arrhythmias in the transgender population is not entirely clear, evidence suggests the need for careful cardiovascular monitoring and consideration of risk factors before initiating hormone therapies.

Palavras-chave : Arrhythmias; Atrial fibrillation; Ventricular; Conduction; Cardiology; Cardiovascular; Exogenous hormones; Electrophysiology.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )